Immunomodulatory Effects of Mixed Hematopoietic Chimerism: Immune Tolerance in Canine Model of Lung Transplantation

Long‐term survival after lung transplantation is limited by acute and chronic graft rejection. Induction of immune tolerance by first establishing mixed hematopoietic chimerism (MC) is a promising strategy to improve outcomes. In a preclinical canine model, stable MC was established in recipients after reduced‐intensity conditioning and hematopoietic cell transplantation from a DLA‐identical donor. Delayed lung transplantation was performed from the stem cell donor without pharmacological immunosuppression. Lung graft survival without loss of function was prolonged in chimeric (n = 5) vs. nonchimeric (n = 7) recipients (p ≤ 0.05, Fisher's test). There were histological changes consistent with low‐grade rejection in 3/5 of the lung grafts in chimeric recipients at ≥1 year. Chimeric recipients after lung transplantation had a normal immune response to a T‐dependent antigen. Compared to normal dogs, there were significant increases of CD4+INFγ+, CD4+IL‐4+ and CD8+ INFγ+ T‐cell subsets in the blood (p < 0.0001 for each of the three T‐cell subsets). Markers for regulatory T‐cell subsets including foxP3, IL10 and TGFβ were also increased in CD3+ T cells from the blood and peripheral tissues of chimeric recipients after lung transplantation. Establishing MC is immunomodulatory and observed changes were consistent with activation of both the effector and regulatory immune response.

[1]  V. Sharma,et al.  HLA-mismatched renal transplantation without maintenance immunosuppression. , 2008, The New England journal of medicine.

[2]  S. Toyooka,et al.  Current status and potential of living-donor lobar lung transplantation. , 2008, Frontiers in Bioscience.

[3]  H. Date,et al.  Living-Donor Lobar Lung Transplantation for Broncho-Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation: Does Bronchiolitis Obliterans Recur in Transplanted Lungs? , 2007, International journal of hematology.

[4]  M. Sykes,et al.  Immune tolerance: mechanisms and application in clinical transplantation , 2007, Journal of internal medicine.

[5]  R. Storb,et al.  Long-term tolerance to kidney allografts in a preclinical canine model. , 2007, Transplantation.

[6]  E. Trulock,et al.  Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  C. Contag,et al.  In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. , 2007, Blood.

[8]  R. Storb,et al.  Partial Donor-Specific Tolerance to Delayed Skin Grafts After Rejection of Hematopoietic Cell Graft , 2006, Transplantation.

[9]  R. Colvin,et al.  Myeloma Responses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: In Vivo and In Vitro Analyses , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  D. Madtes,et al.  Optimizing a canine survival model of orthotopic lung transplantation. , 2006, Transplantation proceedings.

[11]  C. Clercx,et al.  Quantification of mRNA encoding cytokines and chemokines in nasal biopsies from dogs with sino-nasal aspergillosis. , 2006, Veterinary microbiology.

[12]  S. Rosenberg,et al.  IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. , 2006, Blood.

[13]  R. Nash,et al.  Peripheral CD4+CD25+ regulatory T cells (Treg) block alloreactive host anti-donor T cells in canine mixed hematopoietic chimeras , 2006 .

[14]  R. Nash,et al.  Peripheral CD4+CD25+ Regulatory T Cells (Treg) Block Alloreactive Host Anti-Donor T Cells in Canine Mixed Hematopoietic Chimeras. , 2005 .

[15]  J. Berzofsky,et al.  Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells , 2005, Nature Medicine.

[16]  H. Bergmeister,et al.  The Role of Non‐Deletional Tolerance Mechanisms in a Murine Model of Mixed Chimerism with Costimulation Blockade , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  S. Lira,et al.  Lymph Node Occupancy Is Required for the Peripheral Development of Alloantigen-Specific Foxp3+ Regulatory T Cells1 , 2005, The Journal of Immunology.

[18]  S. Ziegler,et al.  De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Aoe,et al.  Living-donor lobar lung transplantation for bronchiolitis obliterans after bone marrow transplantation. , 2005, The Annals of thoracic surgery.

[20]  Junchao Cai,et al.  Lung transplantation in the United States: 1990-2005. , 2005, Clinical transplants.

[21]  R. Storb,et al.  Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  O. Joffre,et al.  Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes. , 2004, Blood.

[23]  M. Sykes,et al.  Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells. , 2004, Blood.

[24]  D. Sachs,et al.  Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine1 , 2004, Transplantation.

[25]  N. Câmara,et al.  Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. , 2003, Blood.

[26]  A. Demetris,et al.  Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naÏve–-donor-strain bone-marrow cells1 , 2003, Transplantation.

[27]  R. Storb,et al.  FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease1 , 2003, Transplantation.

[28]  R. Storb,et al.  Survival of small bowel transplants in canine mixed hematopoietic chimeras: preliminary results. , 2002, Transplantation proceedings.

[29]  R. Cortesini,et al.  Tailoring of immunosuppression in renal and liver allograft recipients displaying donor specific T-suppressor cells. , 2002, Human immunology.

[30]  R. Storb,et al.  Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras1 , 2002, Transplantation.

[31]  D. Sachs,et al.  PERIPHERAL REGULATION OF GRAFT-VERSUS-HOST ALLOREACTIVITY IN MIXED CHIMERIC MINIATURE SWINE , 2001, Transplantation.

[32]  D. Sachs,et al.  Skin-specific alloantigens in miniature swine. , 2001, Transplantation.

[33]  D. Steinmuller.  Skin allograft rejection by stable hematopoietic chimeras that accept organ allografts sill is an enigma. , 2001, Transplantation.

[34]  Colin Borland,et al.  Steady-state measurement of NO and CO lung diffusing capacity on moderate exercise in men. , 2001, Journal of applied physiology.

[35]  J. D. Thompson,et al.  Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation. , 2000, Blood.

[36]  D. Sachs,et al.  Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. , 2000, The Journal of clinical investigation.

[37]  T. Grisar,et al.  Housekeeping genes as internal standards: use and limits. , 1999, Journal of biotechnology.

[38]  H. Deeg,et al.  Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. , 1999, Blood.

[39]  S. Hariharan,et al.  Renal transplantation for end‐stage renal disease following bone marrow transplantation: A report of six cases, with and without immunosuppression , 1999, Clinical transplantation.

[40]  R. Storb,et al.  DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing. , 1998, Tissue antigens.

[41]  M. Sykes,et al.  Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. , 1998, Transplantation.

[42]  D. Steinmuller.  The enigma of skin allograft rejection , 1998 .

[43]  H. Ochs,et al.  Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency. , 1997, Blood.

[44]  I. Bernstein,et al.  Normal immunologic response to a neoantigen, bacteriophage phiX-174, in baboons with long-term lymphohematopoietic reconstitution from highly purified CD34+ Lin- allogeneic marrow cells. , 1997, Blood.

[45]  G. Szot,et al.  Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning , 1997, Nature Medicine.

[46]  H. Deeg,et al.  Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. , 1997, Blood.

[47]  E. Ostrander,et al.  Histocompatibility testing of dog families with highly polymorphic microsatellite markers. , 1996, Transplantation.

[48]  M. Sykes,et al.  Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. , 1996, Transplantation.

[49]  G. Berry,et al.  Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[50]  D. Metcalfe,et al.  Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. , 1995, Journal of immunological methods.

[51]  E. Bryant,et al.  USE OF (CA)n POLYMORPHISMS TO DETERMINE THE ORIGIN OF BLOOD CELLS AFTER ALLOGENEIC CANINE MARROW GRAFTING , 1994, Transplantation.

[52]  M. Sykes,et al.  Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. , 1994, Journal of immunology.

[53]  C. Hewitt,et al.  Partial tolerance in rat renal allograft recipients following multiple blood transfusions and concomitant cyclosporine. , 1990, Transplantation.

[54]  W. Ladiges.  4 – Experimental Techniques Used to Study the Immune System of Dogs and Other Large Animals , 1989 .

[55]  R. Hyatt,et al.  A canine model of bronchial injury induced by nitric acid. Lung mechanics and morphologic features. , 1986, The American review of respiratory disease.

[56]  C. Jadue,et al.  Pulmonary function tests in the detection of small airway obstruction in a canine model of bronchiolitis obliterans. , 1984, The American review of respiratory disease.

[57]  D. Sachs,et al.  Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts , 1984, Nature.

[58]  C. David,et al.  Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. I. H-2 restricted reactions among strains sharing the H-2k haplotype. , 1981, Journal of immunology.

[59]  H. Ochs,et al.  Immunologic Reactivity in Canine Marrow Graft Recipients , 1974, The Journal of Immunology.

[60]  L. Old,et al.  Rejection of Skin Allografts by Radiation Chimaeras: Selective Gene Action in the Specification of Cell Surface Structure , 1970, Nature.

[61]  J. Mead,et al.  Mechanics of respiration in unanesthetized guinea pigs. , 1958, The American journal of physiology.